M&A is the only way to exit.New CEO will seek to sell company.
He have to much shares to sell it on market.
Only way he can exit with profit is M&A.
If results are positive he will try to sell with good profit.
I believe New CEO and his family average down to 0.20~0.30 cents per share.
Only concern I have is New CEO have no background in biotechnology. I checked his profile in LinkedIn and he worked on oil and gas industry. (His family does have some background in biotechnology)
I just wish RP Market cap goes up to 10mil.
5 mill Market cap is a joke with so many potential.